LRCX Financial Statements & Analysis
Complete financial statements for LRCX including income statement, balance sheet, and cash flow statement. Analyze LRCX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
66
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
23.7% ↑
Net Income
40.0% ↑
Gross Margin
2.9% ↑
Operating Margin
11.9% ↑
Balance Sheet
Current Ratio
-25.6% ↓
Debt to Equity
-22.1% ↑
Asset Turnover
8.6% ↑
Cash Flow
Operating Cash Flow
32.7% ↑
Net Cash Flow
111.4% ↑
Free Cash Flow
27.2% ↑
Cash Flow to Debt
47.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 14.91B | 18.44B | 23.7% | |
| Gross Profit | 7.05B | 8.98B | 27.3% | |
| Operating Income | 4.26B | 5.90B | 38.4% | |
| Net Income | 3.83B | 5.36B | 40.0% | |
| EPS | 2.91 | 4.17 | 43.3% | |
| EBITDA | 4.91B | 6.34B | 29.3% | |
| Gross Margin | 47.32% | 48.71% | 2.9% | |
| Operating Margin | 28.61% | 32.01% | 11.9% | |
| Net Income Margin | 25.68% | 29.06% | 13.2% | |
| R&D Expenses | 1.90B | 2.10B | 10.2% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 18.44B | 14.91B | 17.43B | 17.23B | 14.63B |
| Gross Profit | 8.98B | 7.05B | 7.78B | 7.87B | 6.81B |
| Operating Income | 5.90B | 4.26B | 5.17B | 5.38B | 4.48B |
| Net Income | 5.36B | 3.83B | 4.51B | 4.61B | 3.91B |
| EPS | 4.17 | 2.91 | 3.33 | 3.29 | 2.72 |
| EBITDA | 6.34B | 4.91B | 5.64B | 5.71B | 4.89B |
| Gross Margin | 48.71% | 47.32% | 44.63% | 45.69% | 46.53% |
| Operating Margin | 32.01% | 28.61% | 29.69% | 31.24% | 30.64% |
| Net Income Margin | 29.06% | 25.68% | 25.89% | 26.73% | 26.72% |
| R&D Expenses | 2.10B | 1.90B | 1.73B | 1.60B | 1.49B |